X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1591) 1591
Publication (106) 106
Book Review (11) 11
Newspaper Article (9) 9
Book / eBook (7) 7
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1467) 1467
male (954) 954
index medicus (949) 949
female (921) 921
middle aged (802) 802
aged (702) 702
adult (521) 521
bile duct neoplasms - pathology (490) 490
cancer (479) 479
cholangiocarcinoma (418) 418
gastroenterology & hepatology (413) 413
surgery (395) 395
oncology (374) 374
cholangiocarcinoma - pathology (365) 365
liver (312) 312
medicine & public health (305) 305
aged, 80 and over (296) 296
animals (296) 296
prognosis (272) 272
bile ducts, intrahepatic (255) 255
tumors (254) 254
retrospective studies (253) 253
analysis (245) 245
bile ducts, intrahepatic - pathology (244) 244
immunohistochemistry (244) 244
bile duct neoplasms - surgery (229) 229
bile (225) 225
pathology (205) 205
carcinoma (202) 202
expression (190) 190
bile duct neoplasms - metabolism (181) 181
cholangiocarcinoma - metabolism (175) 175
bile duct neoplasms - diagnosis (173) 173
hepatology (173) 173
cholangiocarcinoma - surgery (172) 172
survival (167) 167
gastroenterology (166) 166
abdominal surgery (161) 161
mice (159) 159
medicine (157) 157
liver cancer (156) 156
bile duct neoplasms - immunology (155) 155
treatment outcome (155) 155
liver neoplasms - pathology (154) 154
metastasis (153) 153
immunology (148) 148
bile duct neoplasms - mortality (147) 147
research article (147) 147
risk factors (147) 147
diagnosis, differential (145) 145
intrahepatic cholangiocarcinoma (145) 145
diagnosis (139) 139
vascular surgery (139) 139
cardiac surgery (136) 136
hepatocellular-carcinoma (136) 136
thoracic surgery (136) 136
bile duct neoplasms - genetics (135) 135
cell line, tumor (134) 134
general surgery (134) 134
bile duct (126) 126
cholangiocarcinoma - genetics (123) 123
cholangiocarcinoma - mortality (122) 122
cholangiocarcinoma - diagnosis (119) 119
multidisciplinary sciences (115) 115
research (115) 115
survival rate (115) 115
science (114) 114
health aspects (110) 110
proteins (110) 110
follow-up studies (108) 108
patients (107) 107
cholangiocarcinoma - immunology (102) 102
hepatocellular carcinoma (100) 100
hepatectomy (98) 98
pancreas (97) 97
chemotherapy (95) 95
carcinoma, hepatocellular - pathology (94) 94
medical prognosis (94) 94
neoplasm staging (93) 93
gene expression (92) 92
rodents (92) 92
liver neoplasms - surgery (91) 91
management (90) 90
gastroenterology and hepatology (89) 89
transplantation (88) 88
apoptosis (87) 87
bile ducts, intrahepatic - metabolism (86) 86
bile duct neoplasms - complications (84) 84
liver - pathology (84) 84
bile duct neoplasms - therapy (83) 83
primary sclerosing cholangitis (83) 83
abridged index medicus (82) 82
adenocarcinoma (82) 82
survival analysis (82) 82
gene expression regulation, neoplastic (80) 80
neoplasm invasiveness (80) 80
resection (78) 78
article (77) 77
hilar cholangiocarcinoma (76) 76
medical colleges (75) 75
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1556) 1556
Japanese (20) 20
French (10) 10
Chinese (7) 7
German (6) 6
Russian (4) 4
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 08/2014, Volume 20, Issue 16, pp. 4228 - 4239
Purpose: We performed a phase I trial to investigate the safety, clinical responses, and Wilms' tumor 1 (WT1)-specific immune responses following treatment... 
PROTEIN | ONCOLOGY | WT1 PEPTIDE VACCINE | CD4(+) T-CELLS | ANTIGENS | INDUCTION | IDENTIFICATION | HELPER PEPTIDE | EXPRESSION | GENE WT1 | GEMCITABINE | Carcinoma, Pancreatic Ductal - secondary | Prognosis | Follow-Up Studies | Dendritic Cells - immunology | Humans | Middle Aged | Vaccination | Male | Epitopes - immunology | Bile Duct Neoplasms - immunology | Deoxycytidine - therapeutic use | Peptide Fragments - immunology | WT1 Proteins - immunology | Adult | Carcinoma, Pancreatic Ductal - mortality | Female | Pancreatic Neoplasms - mortality | Carcinoma, Pancreatic Ductal - immunology | T-Lymphocytes, Cytotoxic - immunology | Cholangiocarcinoma - therapy | Biomarkers, Tumor - analysis | Cholangiocarcinoma - secondary | Adenocarcinoma - immunology | Bile Duct Neoplasms - secondary | Pancreatic Neoplasms - pathology | Cholangiocarcinoma - mortality | Histocompatibility Antigens Class I - immunology | Cholangiocarcinoma - immunology | Survival Rate | Carcinoma, Pancreatic Ductal - therapy | Combined Modality Therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Bile Duct Neoplasms - therapy | Histocompatibility Antigens Class II - immunology | Adenocarcinoma - therapy | Bile Duct Neoplasms - mortality | Pancreatic Neoplasms - immunology | Aged | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Bile Ducts, Intrahepatic - immunology | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy
Journal Article
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
Abstract We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 9/2013, Volume 17, Issue 9, pp. 1609 - 1617
Journal Article
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2019, Volume 19, Issue 1, pp. 72 - 10
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2017, Volume 141, Issue 3, pp. 572 - 582
Understanding the mechanisms of immune resistance in pancreatic and ampullary cancers is crucial for the development of suitable biomarkers and effective... 
HLA‐G | galectin‐9 | HVEM | tumor infiltrating lymphocytes | PD‐L1 | PD-L1 | HLA-G | galectin-9 | ANTIBODY | ONCOLOGY | IMMUNOTHERAPY | PATHWAY | POOR-PROGNOSIS | LEUKOCYTE ANTIGEN-G | SURFACE | T-CELLS | Common Bile Duct Neoplasms - mortality | Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism | Pancreatic Neoplasms - metabolism | Prognosis | Humans | Middle Aged | Male | Galanin - metabolism | Ampulla of Vater - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Pancreatic Neoplasms - mortality | Retrospective Studies | Common Bile Duct Neoplasms - immunology | Ampulla of Vater - immunology | B7-H1 Antigen - metabolism | Receptors, Tumor Necrosis Factor, Member 14 - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Common Bile Duct Neoplasms - metabolism | Pancreatic Neoplasms - immunology | Aged | HLA-G Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Immunohistochemistry | Histocompatibility antigens | Lymphocytes | Analysis | Immunotherapy | Pancreatic cancer | HLA histocompatibility antigens | Panels | CD8 antigen | Clinical trials | Complexity | Galectin-9 | Immunology | Foxp3 protein | Bioindicators | Inhibition | Pancreas | Immune system | Cell survival | Adjustment | Tools | Survival | Patients | Cell number | PD-L1 protein | Pancreas transplantation | Biomarkers | Histocompatibility antigen HLA | Cancer | Tumors
Journal Article
Journal Article